Maraviroc in Immunological Non-Responder (INR) HIV-1-infected Subjects
NCT00884858
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Maraviroc
Sponsor
ASST Fatebenefratelli Sacco